Join
This site is intended for healthcare professionals
1
Early DORIS Remission in SLE
2
EMJ Rheumatology 13 [Supplement 1] 2026
3
An FDA Approval for Certain Patients with Endometrial Cancer
4
Is it Time to Label ‘At Risk of Rheumatoid Arthritis’ a Disease?
5
HRRm Testing in mCRPC
A Comprehensive Approach to Care of HAE
AI Shows Promise in Radiotherapy-Associated Cardiovascular Toxicity
Hidradenitis Suppurativa Risk Emerges with Immunotherapy
FDA Clears First Over-the-Counter CGM for Children
MHRA issues warning against promoting unlicensed drugs
EMJ’s latest Flagship Journal
Renal Risk Tied to GI Severity in Paediatric IgA Vasculitis
Psychosocial Screening Tools Could Improve Cancer Care
R/R DLBCL in 2026: Gaps and Next Moves
MVX Score Predicts Mortality Risk in MASLD
Digital Human Proteome Map Opens New Pathways for Cancer Therapy
How Performance Metrics Influence Clinical Decisions
Social Distancing Linked to Lasting Health Burden
Automated CT Analysis May Improve Neurological Recovery
AMJ Oncology 3 [Supplement 4] 2026
Radiation Therapy May Carry Sexual Health Risks in Gynecologic Cancer
Bronchiectasis Outcomes Worsen with Diabetes
Monounsaturated Fatty Acids Linked to Rheumatoid Arthritis Activity
Single-Fraction SBRT Shows Promise as Treatment for Prostate Cancer